Needle phobia affects an estimated 20-30% of the adult population, and the logistics of cold-chain storage, injection site management, and weekly self-administration limit the reach of these therapies to a fraction of the eligible patient population
Starting at too high of a dose or moving to the next higher dose too quickly can exacerbate GI symptoms such as indigestion, nausea, vomiting, diarrhea, or constipation to the point the patient may quit the therapy
You start on a low dose to let your body adjust and reduce side effects, then step up every four weeks until you reach the level that provides the most consistent results
These mice have major kidney abnormalities including enhanced oxidative stress, enhanced activity of the inflammasome, and fibrosis, all features of CKD
Objectives This review highlights the dual metabolic and psychological impacts of GLP-1 and GIP agonists in diabetes and obesity management, emphasizing the need for a holistic, patient-centered approach to optimize treatment outcomes
